|
Volumn 105, Issue 9, 2011, Pages 1115-1122
|
Evaluation of anionic half generation 3.5-6.5 poly(amidoamine) dendrimers as delivery vehicles for the active component of the anticancer drug cisplatin
|
Author keywords
Cancer; Cisplatin; Cytotoxicity; Diffusion NMR; PAMAM dendrimer; Platinum
|
Indexed keywords
CISPLATIN;
DENDRIMER;
POLYAMIDOAMINE;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ANTINEOPLASTIC ACTIVITY;
ARTICLE;
ATOMIC EMISSION SPECTROMETRY;
CANCER CELL CULTURE;
COMPLEX FORMATION;
CONTROLLED STUDY;
DRUG BINDING SITE;
DRUG CYTOTOXICITY;
DRUG DELIVERY SYSTEM;
DRUG DOSE COMPARISON;
DRUG RELEASE;
DRUG TOLERABILITY;
FEMALE;
HUMAN;
HUMAN CELL;
IN VITRO STUDY;
IN VIVO STUDY;
MOLECULAR SIZE;
MOUSE;
NONHUMAN;
OVARY CANCER;
PROTON NUCLEAR MAGNETIC RESONANCE;
TUMOR VOLUME;
TUMOR XENOGRAFT;
5'-GUANYLIC ACID;
ANIMALS;
ANTINEOPLASTIC AGENTS;
CELL LINE, TUMOR;
CELL SURVIVAL;
CISPLATIN;
DENDRIMERS;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DRUG CARRIERS;
DRUG DOSAGE CALCULATIONS;
FEMALE;
HUMANS;
KINETICS;
MAGNETIC RESONANCE SPECTROSCOPY;
MICE;
MICE, NUDE;
OVARIAN NEOPLASMS;
PARTICLE SIZE;
POLYAMINES;
SPECTROPHOTOMETRY, ATOMIC;
XENOGRAFT MODEL ANTITUMOR ASSAYS;
MUS;
|
EID: 79959548466
PISSN: 01620134
EISSN: 18733344
Source Type: Journal
DOI: 10.1016/j.jinorgbio.2011.05.017 Document Type: Article |
Times cited : (93)
|
References (33)
|